Hoth Therapeutics, Inc. (HOTH) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Discover latest Hoth Therapeutics, Inc. (HOTH) short-term stock forecast for year 2025, month by month, and long-term HOTH price prediction for years 2025 to 2050. Check HOTH historical stock performance, analyst ratings (Buy, Sell, or Hold), and stay updated with the latest HOTH news and headlines.
1 Month Prediction
$2.02 [-18.10%]
3 Month Prediction
$1.89 [-23.28%]
6 Month Prediction
$1.00 [-59.51%]
1 Year Prediction
$1.00 [-59.51%]
3 Year Prediction
$1.00 [-59.51%]
5 Year Prediction
$1.00 [-59.51%]
About Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded in 2017 and headquartered in New York, New York. The company develops innovative therapies in dermatology, neurology, and oncology. Hoth's lead product candidate, HT-001, is a topical formulation currently in Phase II clinical trials, which treats skin disorders connected with cancer therapies.
In addition to HT-001, Hoth is developing several other therapeutic candidates, including HT-KIT for mast-cell derived cancers and anaphylaxis, HT-TBI for traumatic brain injury and ischemic stroke, HT-ALZ for Alzheimer's disease and neuroinflammatory conditions, and HT-004 for asthma and allergies. The company also works on the BioLexa Platform, which is in Phase I trials for eczema treatment, and HT-005 for lupus management.
Hoth Therapeutics, Inc. (HOTH) Historical Performance
IPO Date
Hoth Therapeutics, Inc. (NASDAQ:HOTH) went public on 15 February, 2019.
Change
Since inception, HOTH has decreased by 98.08%. In the last 5 years, HOTH has fallen from $104.82 to $2.47, a massive -97.64% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $104.82 and a low of $0.69.
52 Week Range
$0.58
$3.8
The current price $2.47 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
HOTH Stock Price History
Based on HOTH stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the HOTH stock has fallen from $41.75 - $117.5 to $2.47 - $2.47, which is down -98.14%. Currently, the stock follows downward trend.
Here, we have calculated stock range of HOTH, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $41.75 - $117.5 | $71.01 | -46.58 | 1 Year Change |
| 2021 | $16.5 - $58.75 | $36.21 | -72.76 | 2 Year Change |
| 2022 | $4.05 - $17.3 | $10.61 | -92.02 | 3 Year Change |
| 2023 | $1.12 - $5.05 | $2.2 | -98.34 | 4 Year Change |
| 2024 | $0.69 - $1.52 | $1.01 | -99.24 | 5 Year Change |
| 2025 | $2.47 - $2.47 | $2.47 | -98.14 | 6 Year Change |
HOTH Price Performance
6-Month Performance
HOTH stock jumped by 255.91% in the last six months.
1-Year Performance
The stock has trended upwards by 100.81% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 82.67%.
5-Year Performance
In the last 5 years, the stock has gone down by 97.64%.
According to Hoth Therapeutics, Inc.'s historical data, below graph gives us the exact picture of how the HOTH stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 0 year and a decline in 5 years.
2020
61.71% ↓
2021
72.15% ↓
2022
52.73% ↓
2023
81.54% ↓
2024
48.06% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Hoth Therapeutics, Inc. (HOTH) Financials & Stock Analysis
Market Capitalization
Hoth Therapeutics, Inc. has a market capitalization of $17.06M, which places HOTH in the nano-cap category.
Fundamental Analysis
EPS: $-0.31 (Q3), $-2.30 (1Y)
EPS increased 29.17% since last quarter, and decreased 75.79% since last year.
Net Income: $-2.13 M (Q3), $-7.85 M (1Y)
Net Income increased 30.60% since last quarter, and decreased 31.01% since last year.
Free Cash Flow: $-1.63 M (Q3), $-8.45 M (1Y)
Free Cash Flow increased N/A since last quarter, and decreased N/A since last year.
Below, we have listed 12 key indicators for Fundamental analysis for HOTH stock. These indicators help you understand Hoth Therapeutics, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for HOTH stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $0.96 |
| SMA50 | $0.90 |
| SMA200 | $0.96 |
| RSI | 93.01 |
| Beta |
SMA20 < Current Price
This signals HOTH stock is in short-term bullish momentum.
SMA50 < Current Price
This signals HOTH stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals HOTH stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for HOTH stock is Bullish. Out of all indicators, 4 indicates bullish signals, 3 signals bearish trends and 2 gives neutral trends. The HOTH stock forecast was last updated on 08 January, 2025.
Hoth Therapeutics, Inc. (HOTH) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to fall to $1.00 by the end of 2025, and can reach around $3.93 to $0.60 in 2026. And, the long-term forecast suggests that the stock may further drop to $1.68 - $0.93 in 2028, and $0.84 - $1.32 by 2031. So, the HOTH stock shows a strong downward trend in the next several years.
Short-term HOTH Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-02 | $2.02 | -18.22% |
| 2025-03 | $2.30 | -6.88% |
| 2025-04 | $1.90 | -23.08% |
| 2025-05 | $1.73 | -29.96% |
| 2025-06 | $1.37 | -44.53% |
| 2025-07 | $1.00 | -59.51% |
| 2025-08 | $1.56 | -36.84% |
| 2025-09 | $1.00 | -59.51% |
| 2025-10 | $1.00 | -59.51% |
| 2025-11 | $1.00 | -59.51% |
| 2025-12 | $1.00 | -59.51% |
In 2025, the HOTH stock price is expected to fluctuate between $1.0 and $2.3. According to the monthly forecast, the stock could drop to $1.00 by December 2024. If compared to the HOTH's current price, the stock could lose -59.51% by the end of this year.
Long-term HOTH Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $3.93 | $1.55 | $0.60 | -75.71% |
| 2027 | $2.30 | $1.68 | $0.49 | -80.16% |
| 2028 | $1.68 | $0.61 | $0.93 | -62.35% |
| 2029 | $0.99 | $1.31 | $0.04 | -98.38% |
| 2030 | $0.71 | $0.56 | $1.59 | -35.63% |
| 2031 | $0.84 | $1.17 | $1.32 | -46.56% |
| 2032 | $0.18 | $1.61 | $0.92 | -62.75% |
| 2033 | $0.68 | $0.55 | $1.25 | -49.39% |
| 2034 | $1.39 | $1.34 | $2.31 | -6.48% |
| 2035 | $1.39 | $1.09 | $0.87 | -64.78% |
| 2036 | $0.96 | $1.43 | $0.54 | -78.14% |
| 2037 | $1.12 | $0.71 | $1.48 | -40.08% |
| 2038 | $1.29 | $1.42 | $0.67 | -72.87% |
| 2039 | $0.01 | $0.62 | $1.50 | -39.27% |
| 2040 | $1.23 | $0.06 | $1.09 | -55.87% |
| 2041 | $0.67 | $-0.09 | $0.73 | -70.45% |
| 2042 | $1.55 | $0.78 | $0.55 | -77.73% |
| 2043 | $0.71 | $1.43 | $0.38 | -84.62% |
| 2044 | $0.49 | $0.40 | $1.02 | -58.7% |
| 2045 | $1.63 | $0.67 | $1.08 | -56.28% |
| 2046 | $0.58 | $1.06 | $0.56 | -77.33% |
| 2047 | $0.83 | $1.40 | $0.97 | -60.73% |
| 2048 | $0.84 | $0.90 | $1.09 | -55.87% |
| 2049 | $-0.10 | $0.69 | $0.37 | -85.02% |
| 2050 | $1.80 | $0.73 | $0.62 | -74.9% |
| 2051 | $1.07 | $0.14 | $-0.08 | -103.24% |
Hoth Therapeutics, Inc. (HOTH) Stock Price Prediction & Forecast 2025
At the start of 2025, the HOTH stock was at $2.47. Today, it is trading at $2.47, which is 0.00% increase from price at the beginning of the year. By the end of this year, you can expect the stock to fall to $1.00 by December 2025 with a -59.51% change.
Hoth Therapeutics, Inc. (HOTH) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the HOTH stock. During this period, the HOTH's price is forecasted to shift from $3.93 to $1.59, which is -59.54% loss.
In 2026, the stock would possibly open at $3.93, descends to $1.55 by mid-year, and wraps up at $0.60, reflecting a decrease from today's price. Further moving to 2030, the stock can kick off the year at $0.71, drop to $0.56 by mid-year, and finish at $1.59, which is -35.56% change from current price.
Hoth Therapeutics, Inc. (HOTH) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $0.84 to $1.09, which is up -46.72%
In 2031, we can expect HOTH to fluctuate between $0.84 and $1.32, a shift indicating a -46.72% loss by year-end compared to current price. And Until 2040, HOTH can likely vary from $1.09 to $1.23. By the end of 2040, the stock could record a -55.78% fall from today's stock price.
Hoth Therapeutics, Inc. (HOTH) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the HOTH stock can see an a downturn from $0.67 to $0.62 in this period. In 2041, the stock can experience a low of $-0.09 by mid-year, closing the year at $0.73. This results in a -103.53% decrease from today.
Moving towards the end of 2050, HOTH is projected to open the year at $1.80. The stock may dip to $0.73 during mid-year and finish the year at $0.62. Compared to the stock's current price, this translates to an overall loss of -74.85% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
HOTH Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| SANA | Sana Biotechnology, Inc. | - | $4.49 | -0.11% ▼ | $225.59 ▲ |
| NRXP | NRx Pharmaceuticals, Inc. | - | $4.52 | 0.00% ▼ | -12.84 ▼ |
| OTLK | Outlook Therapeutics, Inc. | - | $1.47 | -28.29% ▼ | $648.24 ▲ |
| CABA | Cabaletta Bio, Inc. | - | $2.34 | -38.74% ▼ | $769.02 ▲ |
| PHIO | Phio Pharmaceuticals Corp. | - | $1.76 | -35.29% ▼ | -43.18 ▼ |
Last updated Jan 08 at 8:04 PM
HOTH : Buy, Sell Or Hold?
Analyst Ratings
Based on 1 analysts, 0 rated as a strong buy, 1 recommended a buy, 0 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.So, according to analyst ratings, the recommendation for HOTH stock is Buy.
Expert Analysis
According to HOTH short-term and long-term forecast, Hoth Therapeutics, Inc. shares are projected to go down by 74.9%, and reach a value of $0.62 per share by 2050.
As per technical analysis, indicators show a Bullish sentiment, while Fear & Greed Index stands at 35.714285714285715, which signals Fear. Also, HOTH has recorded 11/30 green days, which reflects a 52.38095238095239% positivity rate with a price volatility of 0.33%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that HOTH stock is undervalued. So, Based on HOTH prediction and analysis, it may be the best time to hold HOTH stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "HOTH” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.